A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisation.
about
Ceftobiprole for the treatment of pneumonia: a European perspectivePharmacokinetics and Dosing of Ceftobiprole Medocaril for the Treatment of Hospital- and Community-Acquired Pneumonia in Different Patient PopulationsCurrent and Future Considerations for the Treatment of Hospital-Acquired PneumoniaCeftobiprole medocaril in the treatment of hospital-acquired pneumoniaSafety profiles of old and new antimicrobials for the treatment of MRSA infections.A phase 3 randomized double-blind comparison of ceftobiprole medocaril versus ceftazidime plus linezolid for the treatment of hospital-acquired pneumoniaCeftobiprole activity against over 60,000 clinical bacterial pathogens isolated in Europe, Turkey, and Israel from 2005 to 2010.Ceftobiprole medocaril: a review of its use in patients with hospital- or community-acquired pneumonia.Reversing resistance: The next generation antibacterials.Genotypic Characterization of Methicillin-Resistant Staphylococcus aureus Recovered at Baseline from Phase 3 Pneumonia Clinical Trials for Ceftobiprole.Summary of ceftaroline fosamil clinical trial studies and clinical safety.Pharmacotherapy for pneumococcal infections: an update.New antibiotics for bad bugs: where are we?Assessment of bias in outcomes reported in trials on pneumonia: a systematic review.Development of novel antibacterial drugs to combat multiple resistant organisms.Participation of elderly adults in randomized controlled trials addressing antibiotic treatment of pneumonia.Vancomycin in the treatment of methicillin-resistant Staphylococcus aureus - a clinician's guide to the science informing current practice.Pharmacokinetic drug evaluation of ceftobiprole for the treatment of MRSA.Managing community acquired pneumonia in the elderly - the next generation of pharmacotherapy on the horizon.Antibiotic resistance: challenges and successes in respiratory infection.Susceptibility to ceftobiprole of respiratory-tract pathogens collected in the United Kingdom and Ireland during 2014-2015
P2860
Q26796463-C31B9A2C-8CE9-4883-9C50-2EF0F728DDADQ28066877-DF85FA7B-0035-4CF4-8C14-6FE229F77320Q28071882-237ED4F1-1B0A-4019-BAAE-7943758315BBQ28085517-45746F4B-5443-43B0-A59E-B2A63030352FQ33429168-5B4B16D5-F820-47AC-9857-ED16512E499DQ34414748-A0328FB5-0A1C-4076-8DAA-2212EA143CE5Q34417616-28AA8409-36CA-4B13-8122-5C192B1DC8FCQ34433342-988DE37F-122E-41FA-93CE-39953B2A3C1CQ35669688-9BE7D668-A5B1-45AB-AB5D-D2622F717DEDQ36489501-B554E2FD-36CD-40CC-89EB-0011D304AC2DQ38035807-B6F3B576-1CCD-4027-94DF-AA3277B63935Q38068919-3B5353F6-1719-4122-AE47-B1BA49139769Q38132217-56B4F13E-FD94-42D1-8001-F303F44D37C7Q38172440-41226C47-1996-4C68-B2FE-860BE02253C0Q38350301-90AE1139-81A6-4A86-AE41-39A76FB80606Q38358209-B9AFEB77-3792-47B8-94C2-A7C12E2C05A8Q38462842-3FDC85B8-C376-4C65-B4C7-C3A5B4696214Q39164183-30CAC9F2-2EBD-45E9-9896-7AF843522615Q39362169-E18802CD-B957-4519-8F34-D42415B08002Q44268356-BFF99CAB-B135-4060-980F-977E1F8FA2F4Q56835140-F914A5B1-6F8A-4E61-9B76-625AAE36F8E4
P2860
A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisation.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A randomised, double-blind tri ...... nia requiring hospitalisation.
@ast
A randomised, double-blind tri ...... nia requiring hospitalisation.
@en
A randomised, double-blind tri ...... nia requiring hospitalisation.
@nl
type
label
A randomised, double-blind tri ...... nia requiring hospitalisation.
@ast
A randomised, double-blind tri ...... nia requiring hospitalisation.
@en
A randomised, double-blind tri ...... nia requiring hospitalisation.
@nl
prefLabel
A randomised, double-blind tri ...... nia requiring hospitalisation.
@ast
A randomised, double-blind tri ...... nia requiring hospitalisation.
@en
A randomised, double-blind tri ...... nia requiring hospitalisation.
@nl
P2093
P921
P1476
A randomised, double-blind tri ...... nia requiring hospitalisation.
@en
P2093
Bart Michiels
Dainius Balis
Deborah Arbit
Gary J Noel
Karen Amsler
Pratibha Kaul
Richard S Strauss
Susan C Nicholson
Thomas M File
P304
P356
10.1016/J.IJANTIMICAG.2011.11.005
P50
P577
2012-01-09T00:00:00Z